For reporters: peptide rules, sources and data
Writing about peptides? Email us for sourced help on FDA status, compounding rules and WADA. Our status tracker is free to cite with credit.
Working on a peptide story? Contact us
Email [email protected]. Please include your outlet, your question and your deadline. Tell us if you need a named source or a call.
What we can help with
- The current FDA, compounding and WADA status of the 26 peptides we track, and when it last changed.
- What a federal policy or rule says, with links to the primary records.
- Checking a peptide status in your draft against those records.
We are not clinicians and do not comment on an individual's care.
Use our data
The FDA Peptide Status Tracker shows a "last verified" date and primary sources on every row, and you can download it as a CSV. It is free to use under CC BY 4.0. Please credit "Living+ Peptides" and link to the tracker.
Who we are
This site is run by Living+, a telehealth company. The site sells nothing. Living+ connects adults with licensed providers online, and its treatment programs include compounded semaglutide, tirzepatide and sermorelin. Compounded medications are not FDA-approved. Please weigh that when you use us as a source.
Found an error?
Email us with the page address and the record that shows the correct information. Material fixes go in the corrections log.